Skip to content
OpenCapital
Get started

Harvard Bioscience HBIO Q4 2024 Annual earnings

Reported March 12, 2025 · Before market open

Revenue$24.6MBeat by $3.6MDiluted EPS$0.06Beat by $0.01
Revenue estimate$21.0M
EPS estimate$0.05

Next report

Aug 10, 2026 (In 4 weeks)
Revenue estimate$21.5M
EPS estimate-$0.21

Versus estimates

Revenue

Q1 2026$20.8MMiss by $445.0KQ4 2025$23.7MBeat by $635.0KQ3 2025$20.6MMiss by $2.5MQ2 2025$20.5MBeat by $1.5MQ1 2025$21.8MBeat by $374.0K
Q4 2024$24.6MBeat by $3.6M

Diluted EPS

Q1 2026-$0.33Beat by $0.29Q4 2025-$0.01Miss by $0.36Q3 2025-$0.01Miss by $0.02Q2 2025-$0.01Beat by $0.02Q1 2025-$0.01Beat by $0.03
Q4 2024$0.06Beat by $0.01

Ask the moment Harvard Bioscience reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Harvard Bioscience report Q4 2024 earnings?
Harvard Bioscience (HBIO) reported Q4 2024 earnings on March 12, 2025 before market open.
What were Harvard Bioscience's Q4 2024 revenue and EPS?
Harvard Bioscience reported revenue of $24.6M and diluted EPS of $0.06 for Q4 2024.
Did Harvard Bioscience beat estimates in Q4 2024?
Revenue beat the consensus estimate of $21.0M by $3.6M. EPS beat the consensus estimate of $0.05 by $0.01.
Where can I find Harvard Bioscience's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001171843-25-001472) directly on SEC EDGAR. The filing index links above go to sec.gov.